Aldeyra Therapeutics Inc (ALDX) Debt by Year
Aldeyra Therapeutics Inc carried $0 in long-term debt against $70.0M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 100.0% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Aldeyra Therapeutics Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ALDX Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $0-100.0% | $15.0M | N/A | $14.9M-3.7% | $15.5M+35.6% | $11.4M-21.3% | $14.5M | N/A | $1.2M-1.5% | $1.2M+2.3% | $1.2M+3.0% | $1.2M+4.1% | $1.1M | N/A | N/A |
| Cash & Equivalents | $70.0M+28.5% | $54.5M-61.8% | $142.8M-1.1% | $144.4M-37.2% | $229.8M+195.1% | $77.9M+75.3% | $44.4M-6.2% | $47.4M+136.5% | $20.0M+66.7% | $12.0M-18.0% | $14.6M+71.8% | $8.5M+161.4% | $3.3M+166.6% | $1.2M | N/A |
ALDX Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | $0-100.0% | $0-100.0% | $0-100.0% | $0 | $15.1M | $15.0M | $15.0M+464.5% | $0-100.0% | $0-100.0% | $0-100.0% | $2.7M-19.6% |
| Cash & Equivalents | $45.1M+9.3% | $65.0M+29.1% | $70.0M+28.5% | $59.3M-12.9% | $41.2M-41.9% | $50.4M-50.9% | $54.5M-61.8% | $68.1M-52.5% | $71.0M-53.2% | $102.5M-37.9% | $142.8M-1.1% | $143.3M+11.4% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Aldeyra Therapeutics Inc financials
Frequently Asked Questions
What was Aldeyra Therapeutics Inc's long-term debt in fiscal year 2025?
Aldeyra Therapeutics Inc carried $0 in long-term debt against $70.0M in cash and equivalents at the end of fiscal year 2025.
How fast is Aldeyra Therapeutics Inc's long-term debt growing?
Aldeyra Therapeutics Inc (ALDX) long-term debt fell by 100.0% year over year, from $15.0M to $0 in fiscal year 2025.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Aldeyra Therapeutics Inc (ALDX) reported on that line in every period on record.